Advertisement

Contrast Media Administration: Safety Issues and Legal Aspects

  • Yousef W. Nielsen
  • Manal Azzouz
  • Henrik S. Thomsen

Abstract

Contrast media (CM) are commonly used in radiological procedures such as radiography, computed tomography (CT), and magnetic resonance imaging (MRI) to enhance the differences between structures or fluids within the body tissue. There are various types of CM, and their chemical and physical properties determine their specific application.

Keywords

Contrast Medium Late Reaction Nephrogenic Systemic Fibrosis Gadopentetate Dimeglumine Market Authorization 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    Aspelin P (2009) Classification and terminology. In: HS Thomsen, JAW Webb (eds) Contrast media safety issues and ESUR Guidelines, 2nd edn. Springer, HeidelbergGoogle Scholar
  2. 2.
    Morcos SK (2009) Chelates and stability. In: HS Thomsen, JAW Webb (eds) Contrast media safety issues and ESUR Guidelines, 2nd edn. Springer, HeidelbergGoogle Scholar
  3. 3.
    Webb JAW (2009) Prevention of acute reactions. In: HS Thomsen, JAW Webb (eds) Contrast media safety issues and ESUR Guidelines, 2nd edn. Springer, HeidelbergGoogle Scholar
  4. 4.
    Thomsen HS, Morcos SK (2004) Contrast Media Safety Committee of the European Society of Urogenital Radiology. Management of acute adverse reactions to contrast media. Eur Radiol 14:476–81PubMedCrossRefGoogle Scholar
  5. 5.
    Bellin MF, Stacul F, Webb JAW et al on behalf of the Contrast Media Safety Committee of the European Society of Uroradiology (2011) Late adverse reactions to intravascular iodine based contrast media: an update. Eur Radiol 21:2305–2310Google Scholar
  6. 6.
    Marckmann P, Skov L, Rossen K et al (2006) Nephrogenic systemic fibrosis: suspected causative role of gadodiamide used for contrast-enhanced magnetic resonance imaging. J Am Soc Nephrol 17:2359–2362PubMedCrossRefGoogle Scholar
  7. 7.
    Thomsen HS (2010) Contrast-enhanced MRI in patients with impaired renal function: recent recommendations to minimize the risk of nephrogenic systemic fibrosis. Solutions in Contrast Imaging 1:1–8Google Scholar
  8. 8.
    Stacul F, van der Molen AJ, Reimer P et al on behalf of the Contrast Media Safety Committee of the European Society of Urogenital Radiology (2011) Contrast induced nephropathy: updated ESUR Contrast Media Safety Committee guidelines. Eur Radiol 21:2527–2541Google Scholar
  9. 9.
    Reimer P, Vosshenrich R (2008) Off-label use of contrast agents. Eur Radiol 18:1096–1101Google Scholar
  10. 10.
    Fairman KA, Curtiss FR (2010) Regulatory actions on the off-label use of prescription drugs: ongoing controversy and contraindication in 2009 and 2010. JMCP 16:629–639PubMedGoogle Scholar

Copyright information

© Springer-Verlag Italia 2012

Authors and Affiliations

  • Yousef W. Nielsen
    • 1
  • Manal Azzouz
    • 1
  • Henrik S. Thomsen
    • 2
  1. 1.Department of Diagnostic RadiologyCopenhagen University HospitalHerlevDenmark
  2. 2.Department of Diagnostic Sciences, Faculty of Health SciencesUniversity of CopenhagenCopenhagenDenmark

Personalised recommendations